Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BN201 single-dose placebo-controlled crossover study in healthy volunteers
NL-OMON42731Withdrawn
- Sponsor
- Bionure
- Start
- Aug 2015
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Trial of BN201 in optic neuritis (ON), sponsored by Bionure. Primary endpoints: Safety and tolerability, Plasma BN201 concentrations and 2 more. Planned start Aug 2015; status: withdrawn.
02
Drugs
BN201
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NL-OMON42731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42731.